Smallcap stock skyrockets 12% after reporting 58% YoY increase in net profits in Q1

Synopsis:
Thyrocare jumped over 12 percent to a 52-week high after strong Q1 results. Net profit rose 73 percent quarter-on-quarter, while revenue grew across pathology, franchise, and partnerships. A rise in FII holdings and a new CFO appointment also boosted investor confidence, driving the stock higher.

A prominent diagnostics company jumped over 12.63 percent today after announcing its Q1 FY26 results, hitting a fresh 52-week high. The strong market reaction was largely driven by a sharp improvement in performance and consistent growth across revenue streams.

The company in focus is Thyrocare Technologies Ltd, which currently has a market capitalization of Rs. 6,884 crore. The stock opened at Rs. 1,251 and surged to an intraday high of Rs. 1,357.85, compared to its previous close of Rs. 1,205.50. This marks a 12.63 percent increase from the last closing price.

What’s the news?

Quarter-on-Quarter Performance for the quarter ended June 2025, revenue from operations rose 3.2 percent to Rs. 193 crore from Rs. 187 crore in the March 2025 quarter. Operating profit grew 1.8 percent to Rs. 58 crore from Rs. 57 crore. Profit before tax rose 6.4 percent to Rs. 50 crore from Rs. 47 crore. Net profit saw a sharp 72.7 percent jump to Rs. 38 crore from Rs. 22 crore, reflecting strong operational efficiency. The company reported an operating profit margin of 30 percent and earnings per share of 7.35.

Year-on-Year Performance, Compared to the same quarter last year, revenue increased 22.9 percent from Rs. 157 crore to Rs. 193 crore. Operating profit jumped 38 percent from Rs. 42 crore to Rs. 58 crore. Profit before tax rose 47 percent from Rs. 34 crore to Rs. 50 crore, while net profit grew 58.3 percent from Rs. 24 crore to Rs. 38 crore.

Thyrocare’s pathology segment reported a 25 percent year-on-year revenue growth, while its radiology business grew by 6 percent Y-o-Y. The franchise segment saw revenue rise 25 percent, and partnership revenue increased by a strong 36 percent.

Also read: Recycling stock skyrockets 18% after company’s net profit increases by 92% YoY

Key Developments During the Quarter

The company announced a leadership transition with Mr. Alok Kumar Jagnani stepping down as CFO to take over as Group CFO of API Holdings, the ultimate holding company. He will also join Thyrocare’s board as a Non-Executive Director. Mr. Vikram Gupta, a Chartered Accountant with over 20 years of experience across Rebel Foods, Tata Play Fiber, and Vodafone Idea, has been appointed as the new CFO effective July 24, 2025.

Foreign institutional investor (FII) holdings increased from 2.41 percent in March 2025 to 3.23 percent in June 2025, indicating growing institutional interest in the stock.

About the Company

Thyrocare Technologies Limited is India’s first fully automated and advanced diagnostic laboratory with a widespread presence across more than 2,000 cities and towns, both in India and overseas. The company focuses on delivering high-quality diagnostic services at affordable prices, catering to patients, hospitals, and laboratories with cost-effective and convenient solutions.

Its Central Processing Laboratory (CPL), located in Navi Mumbai, handles advanced and esoteric testing, while Regional Processing Laboratories (RPLs) are strategically located in key metro cities across India and other parts of Asia. 

Written by – Manan Gangwar 

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Smallcap stock skyrockets 12% after reporting 58% YoY increase in net profits in Q1 appeared first on Trade Brains.